Nestlé has recently unveiled its innovative approach to the evolving food industry with the launch of Vital Pursuit, a new line of frozen meals specifically designed for individuals using GLP-1 based medications like Ozempic and Wegovy. These drugs, known for their effectiveness in weight management, are significantly reshaping consumer eating habits and posing a challenge to traditional food and diet sectors. With a substantial 38% of Americans expressing willingness to use such medications if prescribed, Nestlé is strategically positioning itself to cater to this burgeoning market segment, rather than viewing it as a threat. This move raises important questions about how Ozempic users are changing the landscape of food consumption and purchasing behaviors.
Ozempic Users and Their Grocery Spending Habits
Data indicates that consumers using Ozempic tend to have different spending patterns at supermarkets compared to the average American. Notably, a smaller percentage of Ozempic users, only 15%, spend less than $50 on groceries weekly, while the general population sees 19% falling into this category. Conversely, a larger proportion of Ozempic users (77%) report weekly grocery expenditures exceeding $50, compared to 70% of the broader consumer base.
Interestingly, the influence of GLP-1 drugs on spending seems to extend beyond appetite suppression. The data suggests a correlation between ceasing GLP-1 medication and an increase in grocery spending. Former Ozempic users are even less likely to maintain a weekly grocery bill under $50 and are more inclined to spend over $50 (82% vs. 77%) than current users, indicating a potential rebound in food consumption post-medication.
The Online Grocery Preference Among GLP-1 Users
While supermarkets remain the primary food purchasing destination for Ozempic users, mirroring the general population, they exhibit a greater inclination towards alternative food shopping channels. A significant 25% of Ozempic users utilize online grocery services, considerably higher than the 15% adoption rate among average consumers. Furthermore, they are twice as likely (12% vs. 6%) to subscribe to online meal kit providers, highlighting a preference for convenience and potentially portion-controlled meal options.
Frozen Food Affinity within the Semaglutide User Group
Despite spending slightly more on groceries, the spending habits of Ozempic users reveal specific preferences, particularly in the frozen food category, which bodes well for Nestlé’s Vital Pursuit line. While a majority (85%) of Ozempic users believe fresh food is superior to frozen, this perception doesn’t deter them from purchasing frozen options.
Data highlights that 36% of current Ozempic users prefer foods that can be cooked or eaten directly from frozen, compared to the national average of 30%. This suggests a leaning towards convenience and ease of preparation. Moreover, 36% of Ozempic users cite lifestyle constraints that limit their time for food preparation and cooking, contrasting with a 31% national average. This time-saving aspect of frozen meals aligns well with the needs of this demographic. Additionally, Ozempic users are more prone to stocking up on frozen food favorites (74% vs. 65%), indicating reliance on these readily available options. Brand loyalty is also more pronounced among Ozempic users in the frozen food sector, with 57% preferring to stick to familiar brands compared to 51% of the general population.
In conclusion, while GLP-1 medications like semaglutide may reduce appetite, the fundamental need for food remains. Nestlé’s strategic move into frozen meals tailored for Ozempic users demonstrates a keen understanding of an evolving consumer segment. Food brands would benefit from further exploring the specific needs and preferences of this growing audience to effectively cater to their changing demands in the food market.
Learn more about current and former customers of Ozempic Get in touch
